Modulation of Metabotropic Glutamate Receptors as Potential Treatment for Acute and Chronic Neurodegenerative Disorders

Drug News and Perspectives

Volumn 16, Issue 8, 2003, Pages 513-522

  Lea IV, Paul M ^a   Faden, Alan I ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b EP 12 Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE;

APOPTOSIS; DEGENERATIVE DISEASE; DRUG EFFICACY; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; CELL DEATH; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; FORECASTING; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 0345307648     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2003.16.8.829350     Document Type: Review

References (153)

1. Panter, S.S. and Faden, A.I. Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci Lett 1992, 136: 165-8.
2. Tatton, W.G. and Olanow, C.W. Apoptosis in neurodegenerative diseases: The role of mitochondria. Biochim Biophys Acta 1999, 1410: 195-213.
3. Olanow, C.W. and Tatton, W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999, 22: 123-44.
4. Pohl, D. et al. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 1999, 96: 2508-13.
5. Holscher, C. Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis. Neurobiol Dis 1998, 5: 129-41.
6. Cattaneo, E. et al., Loss of normal huntington function: New developments in Huntington's disease research. Trends Neurosci 2001, 24: 182-8.
7. Martin, L.J. et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998, 46: 281-309.
8. Wang, K.K. Calpain and caspase: Can you tell the difference? Trends Neurosci 2000, 23: 20-6.
9. Nicotera, P. and Lipton, S.A. Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab 1999, 19: 583-91.
10. Choi, D.W. Excitotoxic cell death. J Neurobiol 1992, 23: 1261-76.
11. Choi, D.W., Koh, J.Y. and Peters, S. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J Neurosci 1988, 8: 185-96.
12. Zipfel, G.J. et al. Neuronal apoptosis after CNS injury: The roles of glutamate and calcium. J Neurotrauma 2000, 17: 857-69.
13. Faden, A.I. et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989, 244: 798-800.
14. Katayama, Y. et al. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg 1990, 73: 889-900.
15. Bullock, R. et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 1998, 89: 507-18.
16. Eldadah, B.A. and Faden, A.I. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma 2000, 17: 811-29.
17. Yakovlev, A.G. and Faden, A.I. Caspase-dependent apoptotic pathways in CNS injury. Mol Neurobiol 2001, 24: 131-44.
18. Temple, M.D., OLeary, D.M. and Faden. A.I. The role of glutamate receptors in the pathophysiology of traumatic central nervous system injury. In: Head Trauma: Basic, Preclinical, and Clinical Directions, L.A. Miller, R.L. Hayes, and J.K. Newcomb (Eds.). John Wiley & Sons, Inc., New York. 2001, 87-113.
19. Choi, D.W., Yokoyama, M. and Koh, J. Zinc neurotoxicity in cortical cell culture. Neuroscience 1988, 24: 67-79.
20. Dingledine, R. et al., The glutamate receptor ion channels. Pharmacol Rev 1999, 51: 7-61.
21. Conn, P.J. and Pin, J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997, 37: 205-37.
22. Sun, A. and Cheng, J. Novel targets for therapeutic intervention against ischemic brain injury. Clin Neuropharmacol 1999, 22: 164-71.
23. Li, S. and Tator, C.H. Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury. Neurol Res 2000, 22: 171-80.
24. Lea, P.M. and Faden, A.I. Traumatic brain injury: Developmental differences in glutamate receptor response and the impact on treatment. Ment Retard Dev Disabil Res Rev 2001, 7: 235-48.
25. McIntosh, T.K., Juhler, M. and Wieloch, T. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. J Neurotrauma 1998, 15: 731-69.
26. Meldrum, B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 1990, 2: 27-57.
27. Gill, R. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc Brain Metab Rev 1994, 6: 225-56.
28. Chan, S.L. Griffin, W.S. and Mattson, M.P. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. J Neurosci Res 1999, 57: 315-23.
29. Goforth, P., Ellis, E. and Satin, L. Enhancement of AMPA-mediated current after traumatic injury in cortical neurons. J Neurosci 1999, 19: 7367-74.
30. Goforth, P.B., Ellis, E. and Satin, L. Loss of AMPA receptor desensitization after mechanical injury of cortical neurons is dependent upon NMDA receptors and CAMKII. 30th Ann Meet Soc Neurosci 2000, New Orleans.
31. Simonian, N.A. et al. Kainic acid induces apoptosis in neurons. Neuroscience 1996, 75: 1047-55.
32. Simonian, N.A. et al. Kainate induces apoptosis in neurons. Neuroscience 1996, 74: 675-83.
33. Cebers, G. et al. AMPA neurotoxicity in cultured cerebellar granule neurons: Mode of cell death. Brain Res Bull 1997, 43: 393-403.
34. Sensi, S.L. et al. Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA 1999, 96: 2414-9.
35. Sensi, S.L., Yin, H.Z. and Weiss, J.H. Glutamate triggers preferential Zn2+ flux through Ca2+ permeable AMPA channels and consequent ROS production. Neuroreport 1999, 10: 1723-7.
36. Tan, S. et al. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 1998, 141: 1423-32.
37. Carmody, R.J., McGowan, A.J. and Cotter, T.G. Reactive oxygen species as mediators of photoreceptor apoptosis in vitro. Exp Cell Res 1999, 248: 520-30.
38. Davis, P.K. and Johnson, G.V. Energy metabolism and protein phosphorylation during apoptosis: A phosphorylation study of tau and high-molecular-weight tau in differentiated PC12 cells. Biochem J 1999, 340(Pt 1): 51-8.
39. Gwag, B.J. et al. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 1995, 68: 615-9.
40. Allen, J.W., Knoblach, S.M. and Faden, A.I. Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis. Faseb J 1999, 13: 1875-82.
41. Wahlestedt, C. et al. Antisense oligodeoxy-nucleotides to NMDA-RI receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 1993, 363: 260-3.
42. Sun, F.Y. and Faden, A.I. Pretreatment with antisense oligodeoxynucleotides directed against the NMDA-R1 receptor enhances survival and behavioral recovery following traumatic brain injury in rats. Brain Res 1995, 693: 163-8.
43. Schoepp, D.D., Jane, D.E. and Monn, J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 1999, 38: 1431-76.
44. Anwyl, R. Metabotropic glutamate receptors: Electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 1999, 29: 83-120.
45. Copani, A. et al. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol 1995, 47: 890-7.
46. Stefani, A. et al. The modulation of calcium currents by the activation of mGluRs. Functional implications. Mol Neurobiol 1996,13: 81-95.
47. Yu, S.P. et al. Mediation of neuronal apoptosis by enhancement of ourward potassium current. Science 1997, 278: 114-7.
48. Bond, A. et al. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo. J Pharmacol Exp Ther 2000, 294: 800-9.
49. Bond, A. et al. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport 1998, 9: 1191-3.
50. Allen, J. et al. Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J Pharmacol Exp Ther 1999, 290: 112-20.
51. Di, X.Z., Mullins, T. and Faden, A.I. Novel, potent, and selective group II mGluR agonist LY379268 ameliorates cognitive and motor deficits induced by control cortical impact injury in mouse. J Neurotrauma 2000, 17: 960.
52. Zwienenberg, M. et al. The effect of groups II and III metabotropic glutamate receptor activation on neuronal injury in a rodent model of traumatic brain injury. Neurosurgery 2001, 48): 1119-26; discussion 1126-7.
53. Lafon-Cazal, M. et al. mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons. Eur J Neurosci 1999, 11: 663-72.
54. Bruno, V. et al. Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures. Eur J Pharmacol 1996, 310: 61-6.
55. Bruno, V. et al. Metabotropic glutamate receptors and neurodegeneration. Prog Brain Res 1998, 116: 209-21.
56. Bruno, V. et al. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling. J Neurosci 1997, 17: 1891-7.
57. Bruno, V. et al. Metabotropic glutamate receptors and neuronal degeneration in culture. Adv Neurol 1996, 71: 47-51.
58. Bruno, V. et al. Protective effect of the metabotropic glutamate receptor agonist. DCG-IV, against excitotoxic neuronal death. Eur J Pharmacol 1994, 256: 109-12.
59. Bruno, V. et al. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur J Neurosci 1995, 7: 1906-13.
60. Buisson, A. and Choi, D.W. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxgen-glucose deprivation-induced neuronal death. Neuropharmacology 1995, 34: 1081-7.
61. Kalda. A. and Zharkovsky, A. Metabotropic glutamate receptor agonists protect from oxygen-glucose deprivation- and colchicine-induced apoptosis in primary cultures of cerebellar granule cells. Neuroscience 1999, 92: 7-14.
62. Kalda, A. et al. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res 2000, 853: 370-3.
63. Faden, A.I. et al. Neuroprotective effects of group III mGluR in traumatic neuronal injury. J Neurotrauma 1997, 14: 885-95.
64. Gasparini, F. et al. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther 1999, 289: 1678-87.
65. Henrich-Noack, P. et al. Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage. Neuropharmacology 2000, 39: 911-7.
66. Maiese, K. et al. Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats. Neurosci Lett 1995, 194: 173-6.
67. Maiese, K., Swiriduk, M. and TenBroeke, M. Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity. J Neurochem 1996, 66: 2419-28.
68. Macek, T.A. et al. Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses. J Neurophysiol 1996, 76: 3798-806.
69. Lea, P.M. et al. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glatamate receptor. J Neurophysiol, 2001 85: 1097-106.
70. Bruno, V. et al. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 1998, 18: 9594-600.
71. Coyle, J.T. The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis 1997, 4: 231-8.
72. Neale, J.H., Bzdega, T. and Wroblewska, B. N-Acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 2000, 75: 443-52.
73. Wroblewska, B. et al. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 1997, 69: 174-81.
74. Lea, P.M. and Sarvey, J.M. Modulation of epileptiform burst frequency by the metabotropic glutamate receptor subtype mGluR3. Epilepsy Res 2003, 53: 207-15.
75. Testa, C.M. et al. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 1994, 14(5 Pt 2): 3005-18.
76. Shigemoto, R., Nakanishi, S. and Mizuno, N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat. J Comp Neurol 1992, 322: 121-35.
77. Ohishi, H. et al. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study. J Comp Neurol 1993, 335: 252-66.
78. Ohishi, H. et al. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993, 53: 1009-18.
79. Ghosh, P.K., Baskaran, N. and van den Pol, A.N. Developmentally regulated gene expression of all eight metabotropic glutamate receptors in hypothalamic suprachiasmatic and arcuate nuclei - a PCR analysis. Brain Res Dev Brain Res 1997, 102: 1-12.
80. Reid, S.N. et al. Developmental and sensory-dependent changes of phosphoinositide-linked metabotropic glutamate receptors. J Comp Neurol 1997, 389: 577-83.
81. Simonyi, A., Miller, L.A. and Sun, G.Y. Region-specific decline in the expression of metabotropic glutamate receptor 7 mRNA in rat brain during aging. Brain Res Mol Brain Res 2000, 82: 101-6.
82. Simonyi, A. et al. Age differences in the expression of metabotropic glutamate receptor 1 and inositol 1,4,5-trisphosphate receptor in mouse cerebellum. Neurosci Lett 1998, 244: 29-32.
83. Aronica, E. et al. Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: Homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors. Mol Pharmacol 1993, 44: 981-9.
84. Berthele, A. et al., Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. Brain Res Dev Brain Res 1999, 112: 39-53.
85. Catania, M.V. et al. Metabotropic glutamate receptors are differentially regulated during development. Neuroscience 1994, 61: 481-95.
86. Gong, Q.Z., Phillips, L.L. and Lyeth, B.G. Metabotropic glutamate receptor protein alterations after traumatic brain injury in rats. J Neurotrauma 1999, 16: 893-902.
87. Miller, S., Romano, C. and Cotman, C.W. Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes. J Neurosci 1995, 15: 6103-9.
88. Mills, C.D., Fullwood, S.D. and Hulsebosch, C.E. Changes in metabotropic glutamate receptor expression following spinal cord injury. Exp Neurol 2001, 170: 244-57.
89. Ferraguti, F. et al. Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp Brain Res 2001, 137: 1-11.
90. Hudson, L.J. et al. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenyl-ethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci 2002, 22: 2660-8.
91. Al-Ghoul, W.M., Meeker, R.B. and Greenwood, R.S. Kindled seizures increase metabotropic glutamate receptor expression and function in the rat supraoptic nucleus. J Neurosci Res 1998, 54: 412-23.
92. Simonyi, A., Zhang, J.P. and Sun, G.Y. Changes in mRNA levels for group I metabotropic glutamate receptors following in utero hypoxia-ischemia. Brain Res Dev Brain Res 1999, 112: 31-7.
93. Aronica, E.M. et al. Status epilepticus-induced alterations in metabotropic glutamate receptor expression in young and adult rats. J Neurosci 1997, 17: 8588-95.
94. Blumcke, I. et al. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: Correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients. J Neuropathol Exp Neurol 2000, 59: 1-10.
95. Oka, A. and Takashima, S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol 1999, 97: 275-8.
96. Richardson-Burns, S.M. et al. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus. Biol Psychiatry 2000, 47: 22-8.
97. Cha, J.H. et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci USA 1998, 95: 6480-5.
98. Francesconi, A. and Duvoisin, R.M. Opposing effects of protein kinase C and protein kinase A on metabotropic glutamate receptor signaling: Selective desensitization of the inositol trisphosphate/Ca2+ pathway by phosphorylation of the receptor-G protein-coupling domain. Proc Natl Acad Sci USA 2000, 97: 6185-90.
99. Alagarsamy, S. et al. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat Neurosci 1999, 2: 234-40.
100. Orlando, L.R. et al. Tyrosine phosphorylation of the metabotropic glutamate receptor mGluR5 in striatal neurons. Neuropharmacology 2002, 43: 161-73.
101. Kawabata, S. et al. Diversity of calcium signaling by metabotropic glutamate receptors. J Biol Chem 1998, 273: 17381-5.
102. Tu, J.C. et al. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999, 23: 583-92.
103. Tu, J.C. et al. Homer binds a novel proline-rich motif and links group I metabotropic glutamate receptors with IP3 receptors. Neuron 1998, 21: 717-26.
104. Brakeman, P.R. et al. Homer: A protein that selectively binds metabotropic glutamate receptors. Nature 1997, 386: 284-8.
105. Kammermeier, P.J. et al. Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. J Neurosci 2000, 20: 7238-45.
106. Sheng, M. and Kim, E. The Shank family of scaffold proteins. J Cell Sci 2000, 113(Pt 11): 1851-6.
107. Friberg, I.K., Young, A.B. and Standaert, D.G. Differential localization of the mRNAs for the pertussis toxin insensitive G-protein alpha sub-units Gq, Gll, and Gz in the rat brain, and regulation of their expression after striatal deafferentation. Brain Res Mol Brain Res 1998, 54: 298-310.
108. Chang, M. et al. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells. J Biol Chem 2000, 275: 7021-9.
109. Saugstad, J.A. et al. RGS4 inhibits signaling by group I metabotropic glutamate receptors. J Neurosci 1998, 18: 905-13.
110. Bruno, V. et al. Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology 1995, 34: 1089-98.
111. Strasser, U. et al. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures. Eur J Neurosci 1998, 10: 2848-55.
112. Bruno, V. et al. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): Comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology 1999, 38: 199-207.
113. Agrawal, S.K., Theriault, E. and Fehlings, M.G. Role of group I metabotropic glutamate receptors in traumatic spinal cord white matter injury. J Neurotrauma 1998, 15: 929-41.
114. Mukhin, A., Fan, L. and Faden, A.I. Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury. J Neurosci 1996, 16: 6012-20.
115. Faden, A.I. et al. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improves outcome after brain trauma. Exp Neurol 2001, 167: 435-44.
116. O'Leary, D.M. et al. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol 2000, 131: 1429-37.
117. Movsesyan, V.A. et al. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 2001, 296: 41-7.
118. Allen, J.W., Eldadah, B.A. and Faden, A.I. Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: Exacerbation by selective inhibition of group I metabotropic glutamate receptors. Neuropharmacology 1999, 38: 1243-52.
119. Allen, J.W., Knoblach, S.M. and Faden, A.I. Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death Differ 2000, 7: 470-6.
120. Montoliu, C. et al. Activation of the metabotropic glutamate receptor mGluR5 prevents glutamate toxicity in primary cultures of cerebellar neurons. J Pharmacol Exp Ther 1997, 281: 643-7.
121. Lyeth, B.G. et al. Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats. Exp Neurol 2001, 169: 191-9.
122. Bruno, V. et al. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 2001, 21: 1013-33.
123. Weber, J.T. et al. Alterations in calcium-mediated signal transduction after traumatic injury of cortical neurons. Cell Calcium 1999, 26: 289-99.
124. Faden, A.I., Allen, J.W. and Knoblach, S. Exacerbation of neuronal death by activation of group metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release. 29th Ann Meet Soc Neurosci 1999, Miami Beach, Florida.
125. Battaglia, G. et al. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing GABAergic transmission. Mol Cell Neurosci 2001, 17: 1071-83.
126. Meli, E. et al. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo. Pharmacol Biochem Behav 2002, 73: 439-46.
127. Mills, C.D., Johnson, K.M. and Hulsebosch, C.E. Group I metabotropic glutamate receptory in spinal cord injury: Roles in neuroprotection and the development of chronic central pain. J Neurotrauma 2002, 19: 23-42.
128. Bao, W.L. et al. Selective mGluR5 receptor antagonist of agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res 2001, 922: 173-9.
129. Koh, J.Y., Palmer, E. and Cotman, C.W. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc Natl Acad Sci USA 1991, 88: 9431-5.
130. Ambrosini, A. et al. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol Pharmacol 1995, 47: 1057-64.
131. Valerio, A. et al. Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. Neuroreport 1995, 6: 1317-21.
132. Pizzi, M. et al. Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. Eur J Neurosci 1996, 8: 1516-21.
133. Pizzi, M. et al. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem 1993, 61: 683-9.
134. Pizzi, M. et al. Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: Pivotal role of protein kinase C. Mol Pharmacol 1996, 49: 586-94.
135. Schroder, U.H. et al. Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: Timing and involvement of protein kinase C. Neuropharmacology 1999, 38: 209-16.
136. Vincent, A.M., TenBroeke, M. and Maiese, K. Metabotropic glutamate receptors prevent programmed cell death through the modulation of neuronal endonuctease activity and intracellular pH. Exp Neurol 1999, 155: 79-94.
137. Kozikowski, A.P. et al. Synthesis and metabotropic receptor activity of the novel rigidified glutamate analogues (+)- and (-)-trans-azetidine-2,4-dicarboxylic acid and their N-methyl derivatives. J Med Chem 1993, 36: 2706-8.
138. Copani, A. et al. The metabotropic glutamate receptor mGlu5 controls the onset of developmental apoptosis in cultured cerebellar neurons. Eur J Neurosci 1998, 10: 2173-84.
139. Gasparini, F., Kuhn, R. and Pin, J.P. Allosteric modulators of group I metabotropic glutamate receptors: Novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol 2002, 2: 43-9.
140. Uetsuki, T. et al. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J Neurosci 1999, 19: 6955-64.
141. Kim, T.W. et al. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 1997, 277: 373-6.
142. Harada, J. and Sugimoto, M. Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons. Brain Res 1999, 842: 311-23.
143. Neve, R.L. and Robakis, N.K. Alzheimer's disease: A re-examination of the amyloid hypothesis. Trends Neurosci 1998, 21: 15-9.
144. Iversen, L.L. et al. The toxicity in vitro of beta-amyloid protein. Biochem J 1995, 311(Pt1): 1-16.
145. Selkoe, D.J. Alzheimer's disease: Genotypes, phenotypes, and treatments. Science 1997, 275: 630-1.
146. Bruno, V. et al. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology 2000, 39: 2223-30.
147. Wu, V.W. and Schwartz, J.P. Cell culture models for reactive gliosis: New perspectives. J Neurosci Res 1998, 51: 675-81.
148. Aronica, E. et al. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 2000, 12: 2333-44.
149. Kammermeier, P.J. and Ikeda, S.R. Desensitication of group I metabotropic glutamate receptors in rat sympathetic neurons. J Neurophysiol 2002, 87: 1669-76.
150. Gereau, R.W.T. and Heinemann, S.F. Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5. Neuron 1998, 20: 143-51.
151. Alagarsamy, S. et al. Activation of N-methyl-D-aspartate receptors reverses desensitization of metabotropic glutamate receptor, mGluR5, in native and recombinant systems. Ann NY Acad Sci 1999, 868: 526-30.
152. Ciruela, F., Giacometti, A. and McIlhinney, R.A. Functional regulation of metabotropic glutamate receptor type 1c: A role for phosphorylation in the desensitization of the receptor. FEBS Lett 1999, 462: 278-82.
153. Desai, M.A. et al. Cloning and expression of a human metabotropic glutamate receptor I alpha: Enhanced coupling on cotransfection with a glutamate transporter. Mol Pharmacol 1995, 48: 648-57.